Altamira Therapeutics Ltd. Number Of Shares Outstanding
Altamira Therapeutics Ltd. (CYTOF) had Number Of Shares Outstanding of 5.72 million shares as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:NumberOfSharesOutstanding · last filed 2025-08-29
- 2025-06-30: Number Of Shares Outstanding 5.72M shares.
- 2024-12-31: Number Of Shares Outstanding 4.66M shares.
- 2024-06-30: Number Of Shares Outstanding 2.67M shares.
- 2023-12-31: Number Of Shares Outstanding 1.48M shares.
| Period end | Number Of Shares Outstanding | Number Of Shares Outstanding as first filed |
|---|---|---|
| 2025-06-30 | 5.72M shares 6-K · filed 2025-08-29 | |
| 2024-12-31 | 4.66M shares 6-K · filed 2025-08-29 | |
| 2024-06-30 | 2.67M shares 6-K · filed 2025-08-29 | |
| 2023-12-31 | 1.48M shares 6-K · filed 2025-08-29 | |
| 2023-06-30 | 397.70K shares 6-K · filed 2024-09-24 | 7.95M shares 6-K · filed 2023-09-12 |
| 2022-12-31 | 59.00K shares 20-F · filed 2025-04-30 | 1.18M shares 20-F · filed 2023-05-16 |
| 2022-06-30 | 853.21K shares 6-K · filed 2023-09-12 | |
| 2021-12-31 | 37.41K shares 20-F/A · filed 2024-04-22 | 14.96M shares 20-F · filed 2022-04-12 |
| 2021-06-30 | 682.16K shares 6-K/A · filed 2023-08-21 | 13.64M shares 6-K · filed 2021-09-08 |
| 2020-12-31 | 570.86K shares 6-K/A · filed 2023-08-21 | 11.42M shares 20-F · filed 2021-03-31 |
| 2020-06-30 | 5.06M shares 6-K · filed 2021-09-08 | |
| 2019-12-31 | 4.13M shares 20-F · filed 2022-04-12 | |
| 2018-12-31 | 1.78M shares 20-F · filed 2021-03-31 | 35.52M shares 20-F · filed 2019-03-14 |
| 2017-12-31 | 48.37M shares 20-F · filed 2019-03-14 | |
| 2016-12-31 | 34.33M shares 20-F · filed 2019-03-14 | |
| 2015-12-31 | 129.00 shares 20-F · filed 2020-04-16 | 34.30M shares 20-F · filed 2018-03-22 |